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Abstract 
An intricate interplay between circadian and sleep-wake homeostatic processes regulate 
cognitive performance on specific tasks, and individual differences in circadian preference and sleep 
pressure may contribute to individual differences in distinct neurocognitive functions. Attentional 
performance appears to be particularly sensitive to time of day modulations and the effects of sleep 
deprivation. Consistent with the notion that the neuromodulator, adenosine, plays an important role 
in regulating sleep pressure, pharmacologic and genetic data in animals and humans demonstrate 
that differences in adenosinergic tone affect sleepiness, arousal and vigilant attention in rested and 
sleep-deprived states. Caffeine - the most often consumed stimulant in the world - blocks adenosine 
receptors and normally attenuates the consequences of sleep deprivation on arousal, vigilance and 
attention. Nevertheless, caffeine cannot substitute for sleep, and is virtually ineffective in mitigating 
the impact of severe sleep loss on higher-order cognitive functions. Thus, the available evidence 
suggests that adenosinergic mechanisms, in particular adenosine A2A receptor-mediated signal 
transduction, contribute to waking-induced impairments of attentional processes, whereas 
additional mechanisms must be involved in higher-order cognitive consequences of sleep 
deprivation. Future investigations should further clarify the exact types of cognitive processes 
affected by inappropriate sleep. This research will aid in the quest to better understand the role of 
different brain systems (e.g., adenosine and adenosine receptors) in regulating sleep, and sleep-
related subjective state and cognitive processes. Furthermore, it will provide more detail on the 
underlying mechanisms of the detrimental effects of extended wakefulness, as well as lead to the 
development of effective, evidence-based countermeasures against the health consequences of 
circadian misalignment and chronic sleep restriction. 
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1. Circadian and homeostatic influences permit consolidated periods of wakefulness and sleep  
Wakefulness and sleep take place periodically, at specific times, during the 24-hour light-
dark cycle. These two distinct states result from the interplay between circadian and homeostatic 
oscillators, a concept originally described by the two-process model of sleep-wake regulation 
(Borbély 1982). The circadian process reflects an endogenous, 24-hour variation in the propensity for 
sleep and wakefulness (Borbély 1982). This latter process is controlled by the suprachiasmatic nuclei 
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(SCN) of the anterior hypothalamus, an anatomical structure considered to be the circadian master 
clock in mammals. Human research, conducted under a range of experimental conditions (e.g., 
internal desynchronization of the sleep-wake cycle, forced desynchrony paradigms, fragmented 
sleep-wake cycles, sleep deprivation and sleep displacement), has highlighted the existence of a 
robust drive to maintain wakefulness towards the end of the habitual waking day (Lavie 2001). Thus 
the circadian master clock promotes wakefulness in the early evening, just before habitual time for 
sleep. The positioning of this ‘wake maintenance zone’ (Strogatz et al. 1987), at the end of the 
waking day, may seem paradoxical. However, it is thought that this high circadian-based tendency 
for wakefulness is what prevents humans from falling asleep during the early evening, when 
homeostatic sleep pressure reaches its highest level. The homeostatic process represents an 
hourglass mechanism, which gradually builds up with increasing time awake, and roughly 
exponentially declines during sleep. Thus circadian and homeostatic systems work in opposition to 
ensure a consolidated period of wakefulness (Cajochen et al. 2010). Opposite effects of the two 
processes also occur as the biological night progresses and allows the maintenance of a consolidated 
sleep episode (Dijk and Czeisler 1995; Dijk and Czeisler 1994). The SCN may promote a circadian 
increase in sleep tendency, which counteracts the decrease in homeostatic sleep propensity as the 
individual accumulates sleep. 
 
2. The endogenous circadian clock modulates cognitive performance 
The states of subjective sleepiness and alertness, as well as distinct neurobehavioral 
functions (e.g. cognitive performance on specific tasks), are also influenced by this interplay 
between circadian and homeostatic processes (reviewed by (Cajochen et al. 2004)). Indeed, from a 
cognitive perspective, the two-process model of sleep-wake regulation implies that neurobehavioral 
efficiency may change over the day due to the influence of circadian timing on alertness and task 
performance, due to increasing homeostatic sleep pressure, or due to a combination of both these 
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factors (Carrier and Monk 2000). For example, research incorporating a 40-hour constant routine 
protocol revealed a clear circadian modulation of subjective sleepiness (Karolinska Sleepiness Scale) 
(Gillberg et al. 1994) and cognitive performance (psychomotor vigilance task [PVT]) (Dinges and 
Powell 1985), even in the absence of strong homeostatic sleep pressure (Cajochen et al. 2001; Graw 
et al. 2004). This protocol permits the manipulation of homeostatic sleep pressure by either sleep 
depriving (high sleep pressure) or sleep satiating (low sleep pressure) study participants by the 
allowance of regular nap opportunities throughout the circadian cycle. This circadian modulation of 
subjective state and neurobehavioral performance is organized in a temporal manner which 
prompts maximal performance throughout the waking hours, including the wake-maintenance zone. 
Yet, if testing continues into the biological night (e.g., under sleep deprivation conditions), there is a 
significant decline in performance, which coincides with the decline of the circadian arousal signal. 
Importantly, however, performance deterioration moves in line with the circadian cycle, such that 
an improvement can be observed in the biological morning, once the circadian drive for wakefulness 
takes center stage once again (Cajochen et al. 2004). 
 
2.1. Individual differences in circadian preference modulate human neurobehavioral performance 
Forced desynchrony paradigms can be used to separate the influence of the circadian 
pacemaker from the influence of homeostatic sleep pressure. Here, subjects are isolated from the 
usual ‘zeitgebers’ (i.e., time givers such as light) and for weeks are exposed to an artificial 
sleep/wake schedule with a ‘day’ duration that is significantly shorter (e.g., 19 hours) or longer (e.g., 
28 hours) than the normal 24-hour day. With time, the protocol forces a progressive 
desynchronization of the artificial sleep-wake cycle from the endogenous circadian cycle. Such 
research indicates that the extent to which circadian rhythm modulates performance is largely 
dependent on the extent of homeostatic sleep pressure. Specifically, rising sleep pressure attenuates 
circadian arousal during the subjective evening hours (Dijk and Archer 2009). As a result, even small 
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changes in the relationship between the two processes may have an important effect on an 
individual’s ability to maintain a consistent cognitive performance during the normal waking day 
(Cajochen et al. 2010). In fact, as reviewed by Schmidt and colleagues (2007), large differences in 
circadian parameters can be observed in the temporal disposition of an individual, and this gives rise 
to differential modulations in cognitive performance across the normal waking day. Prominent inter-
individual variation in circadian preference significantly affects the temporal organization of a wealth 
of human behaviors. Morningness-eveningness is the most substantial source of this variation 
(Roenneberg et al. 2003), and is expressed by favorite periods for diurnal activities, such as working 
hours, and specific sleep habits (Taillard et al. 2003). Such behaviors in turn reflect the particular 
chronotype of the individual. The morningness-eveningness chronotype can be assessed using self-
report questionnaires, such as the Morningness-Eveningness Questionnaire (Horne and Östberg 
1976) and the Munich Chronotype Questionnaire (Roenneberg et al. 2003). At one end of the scale 
exist extreme morning types, who show a strong preference for waking up early in the morning and 
find it difficult to remain awake beyond their usual bedtime. At the opposite end of the scale, 
extreme evening-types prefer to go to bed late at night, and experience great difficulty in getting up 
in the morning (Schmidt et al. 2007). It has been suggested that these extreme chronotypes are 
‘phase shifted’ according to their circadian rhythmicity. That is, their peaks and troughs of 
physiological circadian markers (core body temperature, melatonin) occur either earlier (phase 
advance, morning types) or later (phase delay, evening types) in relation to the external clock time, 
as compared to ‘neutral’ individuals who show no strong preference for morningness or eveningness 
(Duffy et al. 2001). Importantly, as well as differences in physiological characteristics, the diurnal 
profile of some neurobehavioral variables is also influenced by chronotype. Accordingly, alertness 
and performance may peak at different clock times, depending on the chronotype of the individual. 
For example, some people may be consistently at their best in the morning, while others are more 
alert and perform better in the evening (Schmidt et al. 2007). 
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To sum up, subjective sleepiness and alertness, and neurobehavioral performance, are 
contingent upon the synchronicity between the individual’s peak periods of circadian arousal and 
the time of day at which testing takes place (Schmidt et al. 2007). Accordingly, it could be intuitively 
assumed that individuals who feel subjectively sleepier and less alert, are more likely to be 
cognitively impaired (Leproult et al. 2003). However, there is accumulating evidence to contradict 
this proposal. For example, sleep deprivation protocols have revealed that subjective sleepiness and 
objective alertness are not always linked to measures of neurobehavioral performance (Leproult et 
al. 2003). In fact, subjective measures of alertness and performance can differ to a great extent (Van 
Dongen et al. 2003). Such findings raise the question as to whether different cognitive domains are 
differentially affected by circadian rhythms, reflected by testing subjects at different times of the 
day. 
 
2.2. Circadian influences differently affect distinct cognitive performance tasks 
Cognitive functioning domains range from simple attention to logical reasoning, working 
memory, long-term memory, and more complex executive functions. A simplified overview and 
classification of the main cognitive processes (attention, memory and executive functions) can be 
seen in Fig. 1 (adapted from (Schmidt et al. 2007)).  
Most studies on the circadian modulation of cognitive function have focused on the impact 
of time of day on vigilance and basic attentional parameters (Schmidt et al. 2007). Historically, 
research revealed a temporal relationship between circadian variations in cognitive performance 
measures and daily fluctuations in physiological variables such as core body temperature. That is, 
when body temperature is high and endogenous melatonin is low, alertness and neurobehavioral 
performance tend to be higher (Kleitman et al. 1938). It was suggested that the circadian-related 
increase in body temperature would indirectly speed up cognitive processing by increasing 
metabolic activity in the brain (Kleitman et al. 1938). However, further research highlighted the role 
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of other, external factors, on time-of-day effects in cognition. More specifically, peak and troughs in 
performance can be attributed to the type and difficulty of the task (e.g., differential working-
memory load) (Folkard et al. 1983). While performance speed on simple repetitive and serial search 
tasks peaks with temperature levels in the evening (Colquhoun 1981; Monk 1982), speed 
performance on more complex cognitive tasks (e.g., logical reasoning tasks) peaks in the late 
morning (Folkard 1975), and performance in short-term memory retention peaks in the early to mid-
morning (Laird 1925). Thus, Bonnet proposed that the optimal time of day for completing a cognitive 
test is largely dependent on the specific parameters of the task, such as its cognitive domain, 
duration and difficulty, the administration method, and the measured variable (Bonnet 2000). 
Alternative data, however, revealed that the selected paradigm (e.g., normal sleep/wake conditions 
vs. 40-hours of enforced wakefulness during constant routine) also influences temporal performance 
(Cajochen et al. 1999). Moreover, compensatory mechanisms, such as motivational factors and 
expectancy due to experience, also play a role in the outcome (Schmidt et al. 2007). 
To date, the picture that emerges is that time-of-day modulations affect performance on a 
range of cognitive tasks, and these performance fluctuations are additionally contingent upon inter-
individual differences in circadian preference (i.e., chronotype). It seems that only highly practiced 
responses (e.g., constant performance tasks) (Valdez et al. 2005) are rather invariant across the day, 
with all other responses being vulnerable to the time-of-day effect during normal day-night 
conditions, as they require a certain degree of control over stimuli and responses. Above attentional 
processes, higher-order cognitive functions, such as working-memory load or executive control, 
appear to be particularly sensitive to time-of-day modulations (Mikulincer et al. 1989). However, 
given the current lack of research in this domain, and the varying choices of protocol and 
experimental control, it is impossible to conclude whether different tasks, involving a range of 
cognitive processes or differing in difficulty, exhibit genuine differences in time-of-day modulations 
(Schmidt et al. 2007). 
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3. Sleep pressure modulates cognitive performance 
3.1. Sleep deprivation affects attentional processes 
According to the ‘wake state instability’ hypothesis (Doran et al. 2001), neurobehavioral 
performance becomes increasingly variable under the influence of elevated sleep pressure due to 
inadvertent microsleep episodes, with brief moments of low arousal that make it difficult to sustain 
attention. This unstable state, which fluctuates from second to second, is characterized by increased 
lapses of attention, increased numbers of errors in response, but also increased compensatory 
efforts resulting in normal reaction times for a short period of time. Over the last two decades, the 
instrument that has emerged as the dominant assay of vigilant attention in paradigms of sleep loss is 
the PVT (Dinges et al. 1985). This task has been widely used in human studies to detect the sustained 
attention (or ‘vigilance’) deficits associated with different types of sleep loss, including chronic sleep 
restriction (Belenky et al. 2003; Van Dongen et al. 2003) and sleep deprivation (Doran et al. 2001; 
Rétey et al. 2006). Importantly, the task is highly sensitive to sleep loss, independent of aptitude, 
lacks learning effects, and its reliability and validity have been amply demonstrated (Lim and Dinges 
2008). The PVT is a test of simple reaction time to a cue that occurs at random inter-stimulus 
intervals. During the task (standard duration of 10 minutes) subjects are instructed to attend to a 
small, rectangular area on a dark screen. They are then required to respond as quickly as possible 
whenever they perceive the appearance of a bright millisecond counter inside this rectangular area. 
Stopping the counter allows subjects to view their reaction time, which serves as feedback for that 
particular trial. Button presses when the counter is not displayed on the screen are counted as false 
starts, which subjects are instructed to avoid. Four dominant findings have emerged from the use of 
the PVT in sleep research protocols. First, sleep deprivation results in an overall slowing of 
responses. Second, sleep deprivation increases the propensity of individuals to lapse for lengthy 
periods (> 500 ms), as well as make false starts. Third, sleep deprivation enhances the time-on-task 
effect, the phenomenon whereby performance worsens across the course of a cognitive task owing 
to fatigue and reduced motivation. Finally, PVT results during extended periods of wakefulness 
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reveal the presence of interacting circadian and homeostatic sleep-regulatory processes (Lim and 
Dinges 2008). 
 
3.2. Sleep deprivation affects higher-order cognitive processes 
Sleep deprivation has been shown to have significant adverse effects on a range of higher-
order cognitive processes, including memory encoding, consolidation, and retrieval (Walker 2008), 
behavioral inhibition (Drummond et al. 2006; Harrison et al. 2007), judgment (Killgore et al. 2007a), 
planning (Horne 1988; Killgore et al. 2009), and divergent thinking capacities (Horne 1988). All such 
processes are believed to draw heavily upon resources in the prefrontal cortex (Killgore et al. 2011). 
Moreover, recent research from rodent experiments has highlighted that sleep deprivation is 
associated with reduced neural activity within brain regions involved in memory (frontal cortex and 
hippocampus), emotion (amygdala), and regulation of the sleep-wake cycle (anterior hypothalamus 
and supraoptic nucleus) (Pierard et al. 2007; Vecsey et al. 2009; Hagwoud et al. 2011). Disruption of 
any of these distinct facets of cognition by sleep deprivation may contribute to noteworthy errors in 
decision-making (reviewed by (Killgore 2010)). Interestingly, however, deficits in executive functions 
have not been observed universally, particularly during shorter durations of sleep deprivation, such 
as one night (Pace-Schott et al. 2009). This suggests that the brain’s executive function systems may 
temporarily compensate for brief sleep loss by utilizing additional cognitive resources via activation 
of alternative brain regions (Drummond et al. 2000; Drummond et al. 2005b). 
More recently, research has focused on clarifying the ways in which sleep deprivation may 
influence well-characterized, higher cognitive processes, such as mental heuristics and emotional 
biases that affect risk assessment and decision-making (Killgore et al. 2012). For example, McKenna 
and colleagues (2007) revealed that when the possible outcomes from a gambling task were framed 
in terms of potential gains, sleep deprivation prompted subjects to take more risks compared to 
when they were well rested. Yet when the same task was presented in terms of potential losses, lack 
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of sleep led them to take fewer risks than usual. Such findings indicate that sleep deprivation may 
lead to greater reliance upon pre-existing cognitive biases. Moreover, functional neuro-imaging 
studies have highlighted that sleep-deprived individuals show differences within brain-reward 
circuitry during risky decision making, and this may bias them toward expectations of gains while 
reducing their focus on losses (Venkatraman et al. 2007). 
Another way that prolonged wakefulness affects decision-making is by reducing the weight 
that a person places on new information when making choices (Dickinson and Drummond 2008). 
Sleep deprived individuals may tend to rely more upon automatic, as opposed to effortful, forms of 
cognitive processing (Killgore et al. 2012). Emotional biasing is a form of automatic processing that 
may influence decision making. Indeed, Damasio (1994) proposed that emotional reactions act as a 
cognitive streamlining function that quickly and efficiently narrows an individual’s choice of options. 
These emotional ‘gut reactions’ prime a person to make choices based on how rewarding or 
unpleasant they found a previous similar experience. In an experimental setting, this emotion-
guided decision making can be investigated using the Iowa Gambling Task (IGT) (Bechara et al. 1994). 
During the computerized program, participants are presented with four decks of cards placed face 
down. Next, players are required to select 100 cards from these four available packs. On card 
selection, they are immediately informed as to whether the card they selected results in a monetary 
gain or a monetary loss. Unbeknownst to the subject, however, two of the decks are ‘good’ decks 
and lead to small but consistent net gains; while the other two decks are ‘bad’ decks, and comprise 
large short-term gains but consistent long-term losses. With regards to the results, healthy 
individuals usually learn from the trial-by-trial feedback and adjust their playing strategy to avoid the 
risky bad decks in favor of the modest, but consistently advantageous, good decks (Bechara 2004). 
However, patients with damage to the ventromedial prefrontal cortex (vmPFC) fail to make this 
adjustment (Bechara 2004). Such findings are in line with evidence that damage to the vmPFC leads 
to shortsightedness for the future (Bechara et al. 1994), as well as neuroimaging data that indicates 
that this brain region plays a key role in the decision making process of the IGT (Li et al. 2010). 
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Importantly, the vmPFC seems to be particularly affected by sleep deprivation. Metabolic 
activity in this brain region is drastically reduced after a single night of sleep loss (Thomas et al. 
2000), whereas increased activation of this area is correlated to a subject’s degree of responsiveness 
to rewards during sleep-deprived decision-making (Venkatraman et al. 2011). Accordingly, in a series 
of studies performed by Killgore and colleagues (2006; 2007b), the IGT was used to assess the effects 
of sleep deprivation on emotionally-guided decision making. As predicted, well-rested subjects 
rapidly learned the contingencies of the task. However, following 49 (Killgore et al. 2006) and 75 
hours (Killgore et al. 2007b) of prolonged wakefulness, the same participants showed a significant 
decline in decision making performance. Specifically, they became progressively more risk-taking 
and short-sighted in decision making, tending to prefer risky short-term gains at the expense of 
incurring long-term losses. Overall, such findings indicate that prolonged sleep loss is associated with 
making choices that begin to favor short-term over long-term outcomes – a pattern paralleling that 
often observed among patients with lesions to the vmPFC (Bechara 2004). Since the vmPFC is 
important in several key cognitive-affective processes (Damasio 1994), alterations in vmPFC 
functioning, or its associated neuro-circuitry following sleep loss, may indeed underlie some of the 
subtle changes in decision-making observed in the two Killgore et al. studies. The findings are also in 
accordance with evidence suggesting that sleep deprivation leads to difficulty incorporating new 
information into ongoing decision making processes, implying an overall decline in cognitive 
flexibility, in favor of greater reliance on automatic cognitive processes (Dickinson and Drummond 
2008). 
Taken together, these behavioral findings suggest that distinct higher-order cognitive 
processes are impaired by sleep deprivation. The sensitivity of the prefrontal cortex to the effects of 
sleep loss may also be reflected in distinct neurophysiological changes associated with sleep 
deprivation. For example, regional cerebral blood flow in this region correlates with 
electroencephalogram (EEG) slow-wave activity (SWA; power density in the 0.75-4.5 Hz range) in 
non-rapid-eye-movement (NREM) sleep (Dang-Vu et al. 2010), which represents the primary 
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physiological marker of sleep homeostasis (Achermann and Borbély 2011). Moreover, not only the 
increase in SWA in NREM sleep, but also the rise in EEG theta (~5-9 Hz range) activity after 
prolonged wakefulness (Cajochen et al. 1995) is larger over anterior than over posterior cortical 
areas (Finelli et al. 2000).  
 
4. Cerebral underpinnings of circadian and homeostatic influences on performance 
Accumulating evidence demonstrates that circadian and homeostatic sleep-wake regulatory 
processes interact in a fine-tuned manner to modulate cognitive performance (Schmidt et al. 2012). 
Neural connections from the SCN indirectly reach target areas implicated in sleep homeostasis, 
including ventro-lateral-preoptic area, tuberomammillary nucleus, lateral hypothalamus, thalamus, 
and brainstem nuclei via its connections to the dorsal medial hypothalamus (Mistlberger 2005). 
Simultaneously, diffuse monoaminergic activating systems are under circadian control and adjoin 
with many thalamo-cortical areas, which suggests that the interaction with sleep homeostasis takes 
place at many different levels (Dijk and Archer 2009). 
Research conducted by Aston-Jones and colleagues indicated that the noradrenergic locus 
coeruleus plays an important role in the circadian regulation of arousal (2005; 2001). Activity in the 
locus coeruleus, combined with its widespread thalamic and cortical connections, may modulate a 
variety of central nervous system functions, including alertness and vigilance, and also higher-order 
cognitive processes (Cajochen et al. 2010). Moreover, a recent study incorporating behavioral 
assessments, EEG, and functional magnetic resonance imaging (fMRI) in morning and evening 
chronotypes indicated that homeostatic sleep pressure exerts an influence on attention-related 
cerebral activity in key structures crucially involved in generating the circadian wake-promoting 
signal, including the locus coeruleus. Specifically, maintenance of optimal attentional performance in 
the evening after a normal waking day was associated with higher activity in evening chronotypes 
than in morning chronotypes in locus coeruleus and anterior hypothalamus, including the SCN 
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(Schmidt et al. 2009). Furthermore, activity in the anterior hypothalamus decreased with increasing 
homeostatic sleep pressure, as indexed by EEG SWA in the first NREM sleep episode. These data 
suggest that circadian and homeostatic interactions contribute to the neural activity that underlies 
diurnal variations in human behavior. Interestingly, the differential activation pattern was observed 
only for optimal performance on the PVT (i.e., the fastest 10th percentile of reaction times) (Schmidt 
et al. 2012), which reflects the phasic ability to recruit the attentional network above normal levels 
(Drummond et al. 2005a). 
The mechanisms by which circadian oscillations in the SCN, as well as circuits controlling for 
states of wakefulness and sleep, interact at the cerebral level in order to regulate arousal and 
cognitive behavior, are yet to be clarified (Cajochen et al. 2010). Conceptually, endogenous ‘sleep 
substances’ may accumulate during wakefulness and modify activity in key areas regulating cortical 
arousal, including brainstem, hypothalamic nuclei and basal forebrain. During sleep, the ‘sleep 
substances’ would dissipate. Although the biochemical ‘substrate’ of sleep homeostasis remains poorly 
understood, adenosine, nitric oxide, prostaglandin D2, tumor necrosis factor alpha, interleukin-1, 
growth-hormone-releasing hormone, and brain-derived neurotrophic factor are considered to be 
important candidate mediators of the consequences of prolonged wakefulness (Krueger et al. 2008). 
 
5. A role for adenosine in homeostatic sleep-wake regulation 
Compelling and converging evidence in animals and humans has accumulated over the past two 
decades to support a role for adenosine and adenosine receptors in sleep-wake regulation (see (Krueger 
et al. 2008; Landolt 2008; Porkka-Heiskanen and Kalinchuk 2011) for reviews). Animal studies suggest 
that the extracellular adenosine concentration in the brain may increase during prolonged 
wakefulness and decline during (recovery) sleep (Porkka-Heiskanen et al. 2000).  
 
5.1. Adenosine formation, transport and metabolism 
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The formation of adenosine in the brain changes in an activity-dependent manner and different 
mechanisms contribute to the appearance of adenosine in extracellular space. Increased energy 
demand during wakefulness leads to the break-down of energy-rich adenine nucleosides such as 
adenosine-tri-phosphate (ATP). Adenosine is formed in neurons by 5’-nucleotidase and transported 
through plasma and intracellular membranes by specialized transporters, including sodium-driven 
concentrative and equilibrative nucleoside transporters (Fig. 2). The concentrative transporters use 
energy to move adenosine into the cell, whereas the equilibrative transporters transport adenosine 
according to the extracellular/intracellular concentration gradient. Elevated intracellular adenosine 
concentrations following increased utilization of ATP in conditions of high energy demand lead to 
release of adenosine. In addition, extracellular adenosine is also formed by ecto-nucleotidases through 
hydrolysis of ATP. Release of ATP from synaptic vesicles occurs along with several other 
neurotransmitters, including the major excitatory neurotransmitter glutamate (Haydon and Carmignoto 
2006). Finally, ATP and glutamate are also released from astrocytes by a recently established process 
referred to as gliotransmission. Molecular genetic manipulations in mice strongly suggest that glial cells 
provide a significant source of extracellular adenosine in the brain (Haydon and Carmignoto 2006). 
Furthermore, astrocyte-derived ATP may activate purinergic (e.g., P2X7) receptors and affect sleep 
independently from adenosine (Krueger et al., 2008; Krueger et al., 2010).  
Clearance of extracellular adenosine mostly occurs through the non-concentrative nucleoside 
transporters (Fredholm et al. 2005). The main intracellular metabolic pathways of adenosine are the 
formation of adenosine-mono-phosphate by adenosine kinase, and the irreversible break-down to 
inosine by adenosine deaminase (ADA). Ecto-ADA also catalyzes the extracellular deamination of 
adenosine. Mainly due to the high activity of adenosine kinase, baseline levels of extracellular adenosine 
usually remain low. The action of ADA, which appears to be more abundantly expressed in astrocytes 
than in neurons (Fredholm et al. 2005), may be particularly important when elevated concentrations of 
adenosine have to be cleared, such as after sleep deprivation. Both, molecular genetic manipulations of 
adenosine kinase in mice (Palchykova et al. 2010), as well as genetically reduced ADA enzymatic 
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activity in humans (Rétey et al. 2005), increase deep slow wave sleep and EEG SWA in NREM sleep. 
These findings provide strong additional support to the idea that adenosine importantly contributes 
to the homeostatic control of sleep. 
 
5.2. Adenosine affects neuronal systems regulating wakefulness and sleep 
Adenosine attenuates the activity of wakefulness/vigilance-promoting neurons in brainstem 
(e.g., locus coeruleus), basal forebrain (BF), and hypothalamus (e.g., tuberomammillary nucleus) and 
my contribute to cortical disfacilitation, a form of inhibition due to reduced activating input from 
ascending cholinergic and monoaminergic pathways. As suggested by intracellular recordings in non-
anaesthetized cats the long-lasting hyperpolarizing potentials in NREM sleep, which provide the 
cellular substrate of EEG SWA, may represent periods of disfacilition (Steriade et al. 2001; Timofeev 
et al. 2001). Moreover, adenosine activates neurons of the hypothalamic ventro-lateral-preoptic 
area by reducing inhibitory -amino-butyric-acid (GABA)-ergic inputs. These neurons fire significantly 
faster after sleep deprivation than they do during normal sleep, indicating that their activity is 
modulated by homeostatic mechanisms representing sleep need (Sherin et al. 1996). 
One current hypothesis based upon biochemical, pharmacological, electrophysiological, and 
behavioral studies postulates that elevated adenosine in the BF plays a distinct role in mediating the 
sleep deprivation-induced increase in sleepiness and homeostatic sleep drive (Basheer et al. 2004; 
Porkka-Heiskanen and Kalinchuk 2011; Strecker et al. 2000). It may be important to note, however, 
that Blanco-Centurion and colleagues highlighted that the actions of adenosine are not restricted to 
the BF region (2006). This research team used a lesion and pharmacological approach to reveal that 
adenosine accumulation in the BF is not necessary for sleep induction, and also that BF cholinergic 
neurons are not essential for sleep drive. Thus, the available data rather suggest that extracellular 
adenosine provides a global feedback signal on a neuronal network, including subcortical and 
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cortical structures (Franks 2008), that regulates important functional aspects of wakefulness and 
sleep. 
 
6. Adenosine A1 and A2A receptors mediate effects of adenosine in sleep-wake regulation 
The cellular effects of adenosine are mediated via four subtypes of G-protein coupled 
adenosine receptors: A1, A2A, A2B, and A3 receptors. In vitro studies indicate that physiological 
concentrations of endogenous adenosine can activate A1, A2A, as well as A3 receptors. Nevertheless, it is 
widely accepted that the high-affinity A1 and A2A receptors are primarily involved in mediating the 
effects of adenosine on sleep and vigilance, at least in humans (Sebastiao and Ribeiro 2009). 
 
6.1. Adenosine A1 receptors and the effects of prolonged wakefulness 
The stimulation of A1 receptors opens several types of K
+-channels, inhibits adenylate cyclase 
through activation of Gi proteins and inactivates transient voltage-dependent Ca
2+-channels. The A1 
receptor is ubiquitously, but not homogenously, expressed in the central nervous system (Bauer and 
Ishiwata 2009). In vivo PET with the selective A1 receptor antagonist, 
18F-CPFPX, revealed highest 
receptor occupancy in striatum and thalamus, as well as temporo-parietal and occipital cortex (Fig. 3A). 
Pre- and post-synaptic activation of A1 receptors inhibits excitatory neurotransmission. This receptor 
subtype, therefore, has long been assumed to play an important role in sleep-wake regulation. 
Pharmacologic and genetic studies in rats and mice, as well as molecular imaging in humans, partly 
support this notion. For example, inducible knock-out of neuronal A1 receptors in mice reduces SWA 
(3.0-4.5 Hz range) in NREM sleep under baseline conditions, and attenuates the homeostatically 
regulated rise in SWA after sleep restriction (Bjorness et al. 2009). Moreover, prolonged wakefulness 
appears to up-regulate A1 receptor binding in subcortical and cortical brain structures in animals and 
humans (Elmenhorst et al. 2009; Elmenhorst et al. 2007). Taken together, these data indicate a role for 
adenosine A1 receptors in mediating distinct consequences of sleep deprivation. 
Urry & Landolt Adenosine, caffeine, and performance 
 19 
 
6.2. Adenosine A2A receptors and the effects of prolonged wakefulness 
The stimulation of A2A receptors increases adenylate cyclase activity through activation of Gs (or 
Golf in striatum) proteins, induces the formation of inositol phosphates, and activates protein kinase A. 
Compared to the A1 receptor, this adenosine receptor subtype is less widely distributed in the brain 
(Bauer and Ishiwata 2009). The highest expression in the human central nervous system is found in 
basal ganglia (particularly in putamen and caudate nucleus) (Fig. 3B). Recent studies in rodents, 
including experiments in knock-out mice, suggest that also A2A receptors contribute to the effects of 
adenosine on sleep. Local administration of the selective A2A receptor agonist, CGS21680, to the 
subarachnoid space adjacent to BF and lateral preoptic area increases c-fos expression in the ventro-
lateral-preoptic area and promotes NREM sleep (Scammell et al. 2001). Direct activation of sleep-
promoting neurons of the ventro-lateral-preoptic region upon stimulation of A2A receptors could 
underlie this effect (Gallopin et al. 2005). Interestingly, preliminary data suggested that mice with A2A 
receptor loss-of-function have reduced sleep and an attenuated sleep rebound after sleep deprivation 
(Hayaishi et al. 2004), indicating that A2A receptors are part of the neural network that regulates sleep 
homeostasis in mammals. These findings are supported by recent data in humans, suggesting that 
genetic variants of the A2A receptor gene (ADORA2A) modulate the sleep deprivation-induced increase 
in EEG SWA in NREM sleep (Bodenmann et al. 2012; Landolt 2012). 
In conclusion, both adenosine A1 and A2A receptor subtypes probably mediate functional effects 
of adenosine after sleep deprivation, whereas distinct effects may be site- and receptor-dependent. 
 
7. Adenosine and sleep-associated cognitive functions 
7.1. Sleep deprivation, adenosine, and vigilant attention 
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While a wealth of evidence supports the concept that modulation of cerebral adenosine 
contributes to the regulation of wakefulness and sleep, it was not until more recently that research 
revealed how this manipulation could also alter neurobehavioral performance (Christie et al. 2008). 
This is poignant given that the BF in particular has been implicated not only in adenosinergic 
mechanisms of sleep regulation but also in the control of sustained attention (Baxter and Chiba 
1999). Thus, the fact that decrements in sustained attention tend to occur concomitantly with 
feelings of sleepiness, is consistent with studies indicating that the same mechanisms implicated in 
the control of the homeostatic sleep drive, are also involved in the regulation of attention (Zaborszky 
et al. 1997). Moreover, neurons within the BF project to components of the cortical sustained 
attention network, whose activation is linked with optimal human performance on the PVT 
(Drummond et al. 2005a). More recently, a rat version of the PVT was developed that enabled 
invasive investigations of the role of adenosine and the BF in the control of behavioral state and 
sustained attention (Christie et al. 2008). Christie and colleagues (2008) utilized this task to assess 
the effects of elevated cerebral adenosine on vigilant performance. The study revealed that rats 
receiving infusions of adenosine in the BF immediately prior to performing the PVT showed 
prolonged response latencies and more performance lapses. The effect was blocked by the co-
administration of the A1 receptor antagonist, 8-cyclopentyl-theophylline, demonstrating that the 
performance decrements were indeed due to elevated adenosine in the BF and apparently mediated 
by A1 receptors, as opposed to other, unrelated factors (Christie et al. 2008). Furthermore, the 
adenosine-induced impairments in sustained attention were similar to those seen in rats undergoing 
sleep deprivation (Cordova et al. 2006). These findings are consistent with the hypothesis that sleep 
loss induces an accumulation of adenosine in the BF, which leads to increased sleepiness and 
reduced vigilance. 
Local cerebral administration of adenosine is not possible in humans, to study its role in 
reduced vigilant attention during sleep deprivation. Nevertheless, relevant information has been 
obtained from studies on a naturally occurring genetic variation of the gene encoding the adenosine 
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metabolising enzyme ADA. A G-to-A single nucleotide polymorphism at nucleotide 22 of the gene 
encoding ADA underlies an Asp-to-Asn amino-acid substitution at codon 8 of the ADA protein. 
Compared to G/G homozygotes, carriers of the variant allele show reduced ADA activity in vitro 
(Battistuzzi et al. 1981; Riksen et al. 2008), and presumably elevated tissue adenosine levels in vivo 
(Hirschhorn et al. 1994). This functional polymorphism not only modulates the duration and intensity of 
slow wave sleep (Bachmann et al. 2012; Mazzotti et al. 2012; Rétey et al. 2005), but also human 
attentional performance in rested and sleep deprived states. More specifically, carriers of the G/A 
genotype (n = 29) performed worse on the d2 focused attention task than G/G homozygotes (n = 
191) (Bachmann et al. 2012). The difference was also present between two prospectively matched 
subgroups of G/A (n = 11) and G/G (n = 11) genotypes. Moreover, sustained attention (Fig. 4A) and 
vigor were reduced, whereas waking EEG alpha activity (8.5-12 Hz), sleepiness, fatigue, and a-
amylase activity in saliva were enhanced in A-allele carriers when compared to G/G homozygotes. 
These convergent data demonstrate that genetic reduction of ADA activity in healthy humans not 
only modulates the quality of sleep, but also the quality of wakefulness, including neurobehavioral 
performance. 
 
7.2. Sleep deprivation, adenosine, and higher-order cognitive functions 
As discussed previously, Bjorness and colleagues (2009) revealed that conditional knock-out of 
the A1 receptor elicits selective attenuation of the SWA rebound following restricted sleep. This research 
team also investigated the effects of this genetic manipulation on working memory. It demonstrated 
that animals lacking the A1 receptor not only showed a reduced rebound SWA response, but they also 
failed to maintain normal cognitive function, although this function was normal when sleep was not 
restricted. Since the attenuation of SWA is associated with compromised working memory 
performance, this indicates a functional role for adenosine A1 receptor-dependent SWA homeostasis in 
maintaining this cognitive ability when sleep is restricted (Bjorness et al. 2009). Here, it is worth noting 
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that the loss of the A1 receptors in the conditional gene deletion used in this study is exclusively 
neuronal. Nevertheless, the source of the adenosine includes both neuronal and non-neuronal, or glia, 
cells (Pascual et al. 2005; Studer et al. 2006). Halassa and colleagues (2009) inhibited the release of 
adenosine from glia cells in transgenic mice expressing a dominant-negative (dn) SNARE domain in 
astrocytes, in order to investigate if astrocytes play a role in sleep-wake regulation. They found that this 
genetic restriction of gliotransmission attenuated the build-up of sleep pressure, and prevented 
memory deficits associated with sleep loss. The data suggest an important role for astrocyte-derived 
adenosine in modulating cognitive consequences of sleep deprivation. Furthermore, the research team 
also conducted pharmacological studies and concluded that astrocytes modulate the accumulation of 
sleep pressure and its cognitive consequences through a pathway involving adenosine A1 receptors 
(Halassa et al. 2009). 
 
8. The adenosine receptor antagonist caffeine and sleep-loss-associated cognitive impairments  
Caffeine is the most widely consumed stimulant in the world. In the M plasma 
concentrations reached after moderate consumption, caffeine acts as a non-selective, competitive 
antagonist at A1 and A2A receptors (Fredholm et al. 1999). Novel PET imaging findings suggest that 
intake of 4-5 cups of coffee (corresponding to ~450 mg caffeine) in a 70-kg volunteer can displace 
endogenous adenosine from 50% of cerebral A1 receptors (Elmenhorst et al. 2012). By contrast, 
other effects of caffeine observed in vitro, such as inhibition of phosphodiesterase, blockade of 
GABAA receptors and Ca
2+ release, require more than 100 times higher doses than adenosine 
receptor antagonism and are toxic in humans (Fredholm 1995). 
 
8.1. Caffeine counteracts sleep deprivation-induced impaired vigilant attention by interfering with 
sleep homeostasis 
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Various studies have examined the effects of caffeine on sustained attention in humans, via 
performance on the PVT. The psychostimulant has been consistently shown to reverse PVT 
impairments in sleepy humans (Balkin et al. 2004; Kamimori et al. 2005; Rétey et al. 2006; Van 
Dongen et al. 2001; Wyatt et al. 2004). Given that physiological doses of caffeine antagonize 
adenosine receptors, such findings are consistent with those of the aforementioned rodent study, 
which revealed decrements in vigilant performance following adenosine administration (Christie et 
al. 2008). 
Wyatt and colleagues (2004) reflected that many studies investigating the neurobehavioral 
benefits of caffeine during sleep loss confounded the two major processes regulating sleep and 
wakefulness: the circadian phase and the duration of prior wakefulness (i.e., homeostatic sleep 
pressure). Specifically, previous research had not clarified if caffeine’s ability to counteract 
performance deficits related to sleep deprivation was related to its interaction with circadian or 
homeostatic signals modulating sleep propensity and performance. The authors stress the 
importance of accounting for variance explained by sleep homeostatic and circadian modulation 
when interpreting data from protocols in which tests are given in only a single administration, such 
as typically occurs in traditional clinical and cognitive neuroscience research. As a result, the 
research team conducted a study to assess the effects of repeated low-dose caffeine administration 
during a 29-day forced desynchrony paradigm. The period of the sleep-wake cycle was scheduled to 
be 42.85 hours (28.57-hour wake episodes and 14.28-hour sleep episodes), and thus far removed 
from the circadian range. This protocol allowed for separate quantification of the circadian, sleep 
homeostatic, and caffeine contributions to performance deficits and improvements. Moreover, the 
42.85-hour cycle simulated the extended wakefulness commonly encountered by medical and 
military personal, or anyone skipping a night of sleep (Wyatt et al. 2004).  
During the study, caffeine was administered during wakefulness at a rate of 0.3 mg per kg 
per hour. The dosage schedule was designed to increase caffeine blood plasma concentrations in 
parallel to the rate of increase in sleep homeostatic drive during wakefulness, and also in line with 
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the potential accumulation of adenosine (Porkka-Heiskanen et al. 2000). Polysomnographic 
recordings were used to monitor each scheduled sleep episode, as well as the majority of each wake 
episode, in order to detect incidences of slow eye movements and unintentional sleep onsets. 
During wake periods, mood and subjective sleepiness were assessed at 30-minute intervals using 
visual analog scales and the Karolinska Sleepiness Scale. Cognitive performance was tested every 2 
hours. 
Post completion of the study, comparison of the placebo and caffeine data revealed that 
rising levels of caffeine significantly reduced wake-dependent deterioration in several measures of 
cognitive functioning, particularly at the circadian performance nadir (Wyatt et al. 2004). Specifically, 
caffeine attenuated performance deficits on the PVT such that the caffeine group showed fewer 
lapses and less impairment in the slowest 10% of reaction times than the placebo group. Caffeine 
also enhanced the ability of subjects to remain consistently awake for extended periods. That is, the 
researchers observed inhibition of EEG-verified accidental sleep onsets during scheduled wake 
episodes. Such findings suggest that individuals receiving caffeine were kept at an earlier, less-severe 
stage of the sleep-onset continuum (Ogilvie et al. 1988), and this held them back from completing 
the full transition to sleep. However, the caffeine group also showed impairment of 
polysomnographically verified sleep during scheduled sleep episodes. Subsequently, the additional 
sleep accumulated by the placebo group during scheduled wake and sleep episodes was associated 
with lower reports of sleepiness, independent of circadian phase or duration of prior scheduled 
wakefulness. Indeed, subjects receiving caffeine self-reported greater impairment of alertness on 
the Karolinska Sleepiness Scale and visual analog scales. A similar paradoxical finding of increased 
subjective sleepiness in participants receiving caffeine over repeated days has been reported in 
other studies (Bonnet and Arand 1992). Thus, the wake-promoting effects of caffeine do not replace 
the restorative effects gained through sleep (Wyatt et al. 2004). 
The evidence of a reduction in accidental sleep onsets during caffeine administration 
supports the concept that caffeine attenuates expression of homeostatic sleep drive. Because the 
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plasma caffeine concentrations of caffeine reached in this study can be expected to affect solely 
adenosine receptors (Fredholm et al. 1999) and because caffeine primarily affects the sleep-wake-
dependent modulation of performance, the present findings are in accordance with the proposed 
role for adenosine in mediating sleep-wake-dependent modulation of sleep propensity and 
associated variation in neurobehavioral functioning (Wyatt et al. 2004). While further research is 
required to elucidate whether mechanisms other than adenosine receptor antagonism or a certain 
degree of tolerance to caffeine over repeated administration could have influenced the 
experimental outcomes, repeated, low-dose caffeine administration holds potential as a 
countermeasure to cognitive deficits and unintended sleep attacks, at the cost of increasing 
subjective sleepiness. 
 
8.2. Caffeine ameliorates deficits in vigilant attention from sleep inertia 
Another study suggested that caffeine reduces impaired vigilant attention associated with 
sleep inertia under conditions of sleep loss. Sleep inertia refers to the impaired cognitive 
performance, grogginess, and tendency to fall back to sleep immediately after waking (Dinges and 
Orne 1981). Van Dongen and colleagues (2001) administered sustained low-dose caffeine (0.3 mg 
per kg per hour, except during naps) or placebo to healthy volunteers during the last 66-hours of an 
88-hour period of extended wakefulness, which included seven 2-hour naps during which 
polysomnographical recordings were made. Performance on the PVT was assessed every 2 hours of 
wakefulness, and also during the sleep inertia experienced after awakening from naps. The results 
revealed that during the placebo condition, testing during sleep inertia was associated with 
significantly impaired psychomotor vigilance. By contrast, these performance decrements were 
absent in the caffeine condition. Thus caffeine was shown to be an effective countermeasure to the 
impaired sustained attention seen during sleep inertia (Van Dongen et al. 2001). 
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Many people consume caffeine-containing beverages in the morning, directly after waking, 
at a time when their homeostatic sleep drive should be reduced. Thus, arguably, there should be no 
need to take the stimulant at this time of the day. Nevertheless, it is possible that following rapid 
awakening from NREM sleep, elevated levels of adenosine, and the corresponding existence of low 
vigilance and high sleepiness (Virus et al. 1983), could persist until adenosine is removed by reuptake 
or metabolism, and hence the phenomenon of sleep inertia (Van Dongen et al. 2001). In accordance 
with this hypothesis, sleep inertia does indeed seem to intensify with prior sleep loss (Dinges et al. 
1985), and it is more pronounced when awakening occurs from NREM sleep, rather than from REM 
sleep (Broughton 1968; Bruck and Pisani 1999). The study of Van Dongen and colleagues (2001) 
involved less than four hours of sleep per 24-hours. Following the sleep periods, 85% of awakenings 
occurred out of NREM sleep in the placebo condition, and subsequent deficits in psychomotor 
vigilance performance, due to sleep inertia, were consistently recorded. However, during the 
caffeine condition, sleep inertia after awakening from nap sleep was not apparent. Moreover, when 
psychomotor vigilance was tested between naps, as opposed to directly afterwards, there was no 
difference between performance in the two conditions. Such results imply that caffeine’s effect was 
specific to sleep inertia. Overall, such findings are in accordance with the hypothesis that adenosine 
may be a neurobiological substrate of the sleep inertia phenomenon (Van Dongen et al. 2001). 
 
8.3. Caffeine reduces false memories after sleep loss by improving arousal and attention 
Human memory is not an exact record of the world and our experiences, but instead is 
influenced by knowledge representations that already exist in the brain (Bartlett 1932). As a result, 
what is retrieved from memory can substantially differ from what was originally encoded (Schacter 
et al. 1998). For example, in some instances, people claim to remember events that in fact never 
happened. These false memories tend to be semantically linked to actually encoded events, and 
subjects are usually very confident about the correctness of these memories (Roediger and 
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Mcdermott 1995). Schacter and colleagues (1998) suggest that the development of false memories 
involves the disruption of the same basic principles of memory formation as the development of 
correct memories. Memory formation involves three distinct stages: encoding (learning); 
consolidation (off-line processing and strengthening of memory traces after encoding); and retrieval 
of the learned material. Research has demonstrated that sleep deprivation may not only impair 
encoding and consolidation of memory, but also memory retrieval (Harrison and Horne 2000). 
Impaired memory retrieval associated with reduced source and reality monitoring may be involved 
in the generation of false memories, and consequently sleep deprivation would be expected to 
enhance their creation (Diekelmann et al. 2008). In a series of experiments, Diekelmann and 
colleagues (2008) investigated sleep-associated mechanisms of false memory generation, using the 
well-established Deese, Roediger, McDermott false memory paradigm (Roediger and Mcdermott 
1995). Here, subjects learned lists of semantically associated words (e.g., ‘night’, ‘dark’, ‘coal’). The 
strongest associate, however, or the ‘theme’ of the list (‘black’ in this example), was not presented 
during learning. Subsequently, memory retrieval was tested 9, 33 or 44 hours after learning. This 
involved the presentation of the previously viewed ‘list’ words, together with the ‘theme’ word (or 
‘critical lure’) and unrelated distracter words. Subjects were required to indicate whether a word 
had been presented during the learning phase or not. Immediately after learning the words, during 
the memory consolidation phase, participants either slept or stayed awake. At word retrieval, they 
were or were not acutely sleep deprived. The study revealed that when participants were sleep 
deprived during retrieval of stored words, there was a significant increase in the number of false 
memories of theme words. That is, they reported that they had been presented with a specific word 
during the learning phase, when in fact they had not. Of particular relevance to the present 
discussion was the finding that this distortion of memory was removed by administering caffeine to 
the sleep deprived subjects prior to retrieval testing. Such evidence indicates that adenosinergic 
mechanisms are involved in the depletion of specific cognitive resources, which elicits the 
generation of false memories associated with sleep loss (Diekelmann et al. 2008). It is possible that 
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caffeine improved reduced arousal and sustained attention after sleep deprivation, which rely on a 
prefrontal-parietal network, basal forebrain and thalamus, and are known to be implicated in 
memory functions. 
 
8.4. Caffeine has weak potency to improve impaired higher-order and executive functions after sleep 
deprivation 
Much research regarding the effects of caffeine on performance during sleep deprivation 
has focused primarily on measures of simple cognitive processes, as opposed to memory and 
executive functions. Yet, if a subjective state or cognitive function is impaired by sleep loss, then it 
may be expected that this decrement would be reversed by caffeine (Wyatt et al. 2004). To test this 
hypothesis, Wyatt and colleagues (2004) not only studied the effects of caffeine on PVT performance 
during forced desynchrony, but also assessed short-term memory (Probed Recall Memory Task) and 
cognitive throughput (Addition Task, Digit Symbol Substitution Task). Indeed, caffeine tended to 
reduce the wake-dependent impairment of short-term memory and attenuated performance 
deficits in the two cognitive throughput tasks when compared to placebo. Thus, the potential 
benefits of caffeine on higher-order cognitive performance warrant further investigation. 
Killgore and colleagues (2012) performed an investigation into the potential benefits of 
stimulants on decision making during sleep deprivation. The protocol required subjects to perform 
the IGT at four time points throughout a period comprising 61 hours of sleep deprivation and 12 
hours of recovery sleep. After 44 hours of wakefulness, participants received a double-blind 
administration of caffeine (600 mg), d-amphetamine (20 mg), modafinil (400 mg), or placebo. As 
predicted, sleep deprivation was found to alter normal decision making, which was consistent with 
the team’s previous research (Killgore et al. 2006; Killgore et al. 2007b). Yet, perhaps the most 
important finding was the fact that although all three stimulants were highly effective at reducing 
subjective sleepiness and sustaining psychomotor vigilance relative to placebo, none of the 
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pharmacologic agents provided any significant enhancement of decision-making performance on the 
IGT. In fact, performance was similar to placebo for all stimulant groups (Killgore et al. 2012). It 
should be noted here that IGT performance was unrelated to self-reported sleepiness or 
psychomotor vigilance performance during the administration of the stimulants, which implies that 
the deficits observed in decision-making were independent of differences in alertness. That is, 
despite subjects on stimulants being awake, alert, and able to sustain psychomotor vigilance, they 
were not any better than placebo on the IGT (Killgore et al. 2012). These findings are consistent with 
a previous study which evaluated the effect of caffeine on sleep-deprived IGT performance (Killgore 
et al. 2007b). In that study, repeated doses of caffeine (200 mg every 2 hours) during the overnight 
sessions, up to 3 hours before each IGT, had virtually no effect on performance relative to placebo at 
either 51 or 75 hours of sleep deprivation. Similarly, caffeine had no significant effect on the time 
taken for subjects to make various types of moral judgments after 53 hours of prolonged 
wakefulness (Killgore et al. 2007b). 
In fact, other studies have also reported limited effects of various stimulants on higher-order 
cognition and executive functions during sleep loss. For example, Gottselig and colleagues (2006) 
revealed that caffeine was effective at restoring simple aspects of cognitive functioning, such as 
attention. Yet, the stimulant failed to restore a more complex aspect of executive function, random 
number generation (Brugger et al. 1996), a cognitive process that relies on the prefrontal cortex 
(Gottselig et al. 2006).  
Some evidence indicates that the effectiveness of stimulants, including caffeine, on 
executive functions may be task specific, and depend upon the underlying executive function 
systems targeted by different stimulant (Killgore et al. 2009). For instance, participants’ performance 
on a behavioral measure of risk-taking and impulsive responding (the Balloon Analog Risk Task) was 
relatively resistant to the effects of sleep loss until about 75 hours of continuous wakefulness, at 
which point there was a clear increase in risky decision making (Killgore et al. 2011). It is noteworthy 
that caffeine appeared to mitigate this surge in risk-taking at extreme sleep deprivation (Killgore et 
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al. 2011). This finding suggests that the types of executive functions measured by the Iowa Gambling 
Task, the random number generation task, and the Balloon Analog Risk Task may involve different 
brain systems that are differentially affected by caffeine, and thus adenosinergic mechanisms. 
 
9. Inter-individual differences in the effects of caffeine 
More recently, there has been increased interest in inter-individual differences in the 
impairment of neurobehavioral functions from sleep loss and in the effectiveness of common 
pharmacological countermeasures such as caffeine. The clarification of the mechanisms underlying 
these differences is relevant because they would reveal insights into the neurophysiological 
regulation of human wakefulness and sleep. Moreover, they are also of clinical importance because 
they may highlight individuals at greater risk for impaired neurobehavioral performance and 
reduced health associated with prolonged wakefulness and shift work (Rajaratnam and Arendt 
2001). In humans, sleep loss produces a range of cognitive deficits, including reduction in vigilance, 
working memory and executive function. Yet, there are large inter-individual differences in these 
deficits, which account for a substantial portion of the variance. In a study involving repeated 
exposure to sleep deprivation under controlled laboratory conditions, Van Dongen and colleagues 
(2004) demonstrated that sleep loss negatively influences measures of subjective sleepiness, fatigue 
and mood, behavioral alertness (sustained attention), and cognitive processing capability (working 
memory). While these impairments were stable within individuals, there were significant differences 
among individuals that were not merely a consequence of a different sleep history. Thus, the 
authors suggested that these individual differences represented trait-like differential vulnerability to 
sleep loss. 
 
9.1. Adenosinergic mechanisms contribute to inter-individual differences in vigilant attention during 
prolonged wakefulness 
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Given the evidence discussed above, Rétey and colleagues (2006) predicted that 
adenosinergic mechanisms play a role for inter-individual differences in neurobehavioral function 
during prolonged wakefulness. To test this hypothesis, the research team investigated the combined 
effects of sleep deprivation and caffeine on PVT speed and EEG activity in individuals that rated 
themselves as either caffeine-sensitive or caffeine-insensitive. It was previously suggested that 
subjective differences in the psychostimulant effects of caffeine might reflect genetically determined 
differences in the adenosinergic system (Alsene et al. 2003; Goldstein et al. 1965). Thus it was 
hypothesized that subjects from both ends of the caffeine-sensitivity spectrum would not only react 
differently to caffeine, but also show different sleep-deprivation induced changes in neurobehavioral 
function and the EEG (Rétey et al. 2006). The study protocol required the 12 subjectively caffeine-
sensitive and 10 caffeine-insensitive subjects to complete two experimental blocks separated by one 
week. Each block consisted of 4 nights and 2 days in the sleep laboratory. After 2 consecutive, 8-
hour, nocturnal sleep recordings (comprising an ‘adaptation’ night and baseline assessment), the 
subjects were kept awake for 40 hours under constant supervision by members of the research 
team. During this period of prolonged wakefulness, EEG topography was assessed every three hours, 
as well as PVT and random number generation performance. After both 11 and 23 hours of sleep 
deprivation, participants received a capsule with either 200 mg caffeine or placebo, according to a 
randomized, double-blind, cross-over design. Finally, a 10.5-hour recovery night was followed by a 
final waking EEG, PVT, and random number generation assessment.  
Analysis of the results revealed that while there were no differences at baseline in optimal 
PVT performance (i.e., the fastest 10th percentile of reaction times) between subjectively caffeine-
sensitive and -insensitive men, there were differences in the regional EEG power distribution 
between these groups in the theta range in waking after a baseline night of sleep. These differences 
were enhanced by sleep deprivation in the antero-posterior power gradients in the waking EEG, and 
also induced differences in the PVT (Rétey et al. 2006).  Here, prolonged wakefulness impaired PVT 
speed more in self-rated caffeine-sensitive individuals than in caffeine-insensitive individuals. Such 
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observations are in accordance with functional imaging studies indicating that the vulnerability to 
sleep deprivation-induced performance decline in working memory is linked with baseline 
differences in task-related cortical activation (Mu et al. 2005). Taken together, the findings suggest 
that physiological variables recorded during baseline assessment could be useful future predictors of 
individual vulnerability to sleep deprivation. 
Importantly, caffeine counteracted the sleep-loss-induced PVT differences between the two 
groups of subjects. Moreover, correlation analyses revealed that those individuals with the largest 
neurobehavioral impairment from sleep deprivation benefited the most from the stimulant action of 
caffeine. Interestingly, optimal PVT performance has been shown to activate a cortical sustained 
attention network and the motor system including the striatum (Drummond et al. 2005a). This 
region shows prominent expression of adenosine A2A receptors (Fig. 3B) (Bauer and Ishiwata 2009). 
Furthermore, this adenosine receptor subgroup was shown to be responsible for the wakefulness-
promoting effect of caffeine (Huang et al. 2005; Lazarus et al. 2011), and a common c.1976T>C 
polymorphism of the A2A receptor gene has been associated with inter-individual differences in EEG 
theta power during wakefulness and sleep (Rétey et al. 2005). Therefore, Rétey and colleagues 
suggested that this adenosine receptor subtype plays a role in determining the differences between 
individuals in their vulnerability to impairments of neurobehavioral performance following sleep loss 
(Rétey et al. 2006). 
With regards the EEG topography data, the present study found that the overall effect of 
sleep loss on the waking EEG was consistent with previous studies (Cajochen et al. 2001). Yet, there 
were noteworthy differences between the individuals which emerged following analysis of regional 
power distributions between fronto-central and parieto-occipital EEG derivations. Specifically, both 
the effects of sleep loss and caffeine on antero-posterior power gradients in the theta range tended 
to be more prominent in caffeine-sensitive subjects than in caffeine-insensitive participants. These 
differences mirrored the inter-individual differences in the effects of sleep deprivation and caffeine 
on sustained vigilant attention. Here it may be important to remember that frontal theta activity 
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reflects the alternative activation of brain regions linked with continuous attention - the prefrontal 
cortex and anterior cingulate cortex (Asada et al. 1999). Moreover, a combined EEG and fMRI study 
highlighted a positive correlation between theta activity (5-9.5 Hz range) in waking and the fMRI 
signal of the right dorso-lateral prefrontal and superior parietal cortices (Foucher et al. 2004). In 
accordance with the interpretation that these areas are involved in arousal, as well as the 
maintenance of attention, it has also been reported that optimal PVT speed after sleep deprivation 
depends on activation of a fronto-parietal sustained attention network and frontal cortical regions 
(Drummond et al. 2005a). Rétey and colleagues (2006) thus propose that their EEG data supports 
brain imaging studies which show that changes in activation after sleep deprivation in fronto-parietal 
regions are related to individual differences in attential impairment from sleep loss, and moreover, 
that adenosinergic mechanisms may contribute to these differences. 
 
9.2. Polymorphisms of ADORA2A modulate the individual response to caffeine after sleep deprivation 
More recent research has demonstrated that in humans, genetic variation of the adenosine 
A2A receptor gene, ADORA2A, mediates an individuals’ susceptibility to panic disorder and individual 
differences in anxiety-related personality, habitual caffeine consumption, and arousal (Cornelis et al. 
2007; Deckert et al. 1998; Hamilton et al. 2004; Hohoff et al. 2010). Furthermore, individual 
anxiogenic and sleep-disrupting responses to caffeine have been consistently associated with a 
common C-to-T substitution at nucleotide 1976 of ADORA2A (Alsene et al. 2003; Childs et al. 2008; 
Rétey et al. 2007; Rogers et al. 2010). The T-allele of this polymorphism  predisposes Caucasian 
individuals to anxiety following caffeine consumption (Alsene et al. 2003; Childs et al. 2008; Rogers 
et al. 2010), while the C-allele seems to relay a tendency towards disturbed sleep following ingestion 
of the stimulant (Rétey et al. 2007). 
In a recent publication, Bodenmann and colleagues (2012) examined the effects of genetic 
variation of ADORA2A and sleep deprivation on subjective sleepiness, PVT, waking and sleep EEG, 
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and the pharmacogenetic response to the stimulants caffeine and modafinil. The study revealed that 
the carriers of a distinct ADORA2A haplotype (haplotype HT4 - these individuals carry a T-allele at 
nucleotide 1976) showed greater vigilance during sleep loss than carriers of non-HT4 haplotype 
alleles (Fig. 4B). Furthermore, caffeine did not counteract the consequences of prolonged 
wakefulness on psychomotor speed and EEG delta activity in the carriers of haplotype HT4. On the 
other hand, modafinil, which does not interact with A2A receptors, influenced the effects of 
prolonged wakefulness irrespective of ADORA2A haplotype. It was concluded that genetic variation 
of ADORA2A not only affects psychomotor response speed, but also modulates the effects of 
caffeine on neurobehavioral and neurophysiological aspects of sleep-wake regulation (Bodenmann 
et al. 2012).  
 
10. Conclusions 
Consistent findings accumulated over the past decades which suggest that attentional 
performance is particularly sensitive to time of day modulations and the effects of sleep loss. 
Efferent projections from the circadian master clock located in the SCN form connections to the 
dorso-medial hypothalamus, which sends out afferents to cholinergic and monoaminergic neurons 
in BF, brainstem, and hypothalamic nuclei involved in promoting behavioral arousal, attention and 
cortical activation. The ‘sleep substance’, adenosine, is released in activity-dependent manner and 
activates A1 and A2A receptors located in these and other brain regions, including basal ganglia and 
cortex. Adenosine induces global cortical disfacilitation by reducing the activating input from the 
ascending arousal pathways and actively excites sleep-active neurons in the ventro-lateral-preoptic 
area of the hypothalamus. We, thus, hypothesized that adenosine contributes to the regulation of 
brain functions modulated by the sleep-wake cycle, in particular to sleepiness and sustained 
attention which are heavily affected by sleep loss (Lo et al. 2012). Indeed, convergent pharmacologic 
and genetic data in animals and humans support the notion that differences in adenosinergic tone in 
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the central nervous system primarily affect vigilant attention. Importantly, the differences appear to 
be present in rested and sleep-deprived states and do not reflect different accumulation of 
homeostatic sleep pressure during extended wakefulness or differential vulnerability to the effects 
of sleep loss. 
Further support for a role for adenosine in modulating sleep pressure and associated 
variation in arousal and attention stems from the effects of the adenosine receptor antagonist, 
caffeine. Acute and repeated administration of the stimulant attenuate subjective, 
neurophysiological and neurobehavioral consequences of moderate acute sleep deprivation. It is 
evident, however, that caffeine cannot substitute for sleep, and commonly consumed doses of the 
stimulant do not improve higher-order cognitive functions that are compromised after severe sleep 
loss. These findings indicate that adenosinergic mechanisms may be particularly important for the 
initial effects of sleep deprivation and that additional mechanisms contribute to the cognitive 
consequences of severe sleep deficits. 
Caffeine is a non-selective A1 and A2A receptor antagonist, and these two adenosine receptor 
subtypes may play different roles in sleep-wake associated brain functions. Recent studies in knock-
out animals suggest that the psychostimulant and the arousal effects of the xanthine are mainly 
mediated by A2A receptors. This conclusion is supported by findings in humans showing that 
common genetic variation of ADORA2A determines individual effects of caffeine on vigilant attention 
during sleep deprivation. Thus, caffeine fails to counteract the waking-induced impairment of PVT 
performance in haplotype HT4, whereas it is normally effective in non-HT4 allele carriers. The 
findings demonstrate a role for A2A receptors in the effects of prolonged wakefulness on vigilant 
attention. 
 
11. Perspectives 
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Further research will aim at elucidating the involvement of adenosine in downstream 
mechanisms underlying sleep deprivation-induced impairment of cognitive functions and synaptic 
plasticity. Recent evidence indicates that changes in adenosine during prolonged wakefulness are 
implicated in plasticity deficits (Dias et al. 2013). Neuronal and glial-derived adenosine may lead to 
increased sleepiness after sleep loss and signal an increased need for sleep to balance adenosine. 
Thus, sleep may serve to counteract overstimulation of the brain and excitotoxicity associated with 
prolonged wakefulness. Adenosine reduces excitatory neurotransmission by stimulating inhibitory A1 
receptors. The A1 receptor appears to be required for disruption of hippocampal long-term 
potentiation by a spontaneous low-frequency EEG pattern, which is typical for deep NREM sleep and 
could provide a stimulus for plasticity reversal (Dias et al. 2013). Prolonged A1 receptor activation 
also induces dynamic changes in the synaptic expression of N-Methyl-D-aspartic acid (NMDA) 
receptors that may reversibly adjust the threshold for plasticity induction (Kopp et al. 2006). 
On the other hand, adenosine actively promotes sleep by stimulating excitatory A2A 
receptors in ventro-lateral preoptic area of the hypothalamus. Activation of A2A receptors by 
endogenous adenosine is required for hippocampal long-term potentiation by brain-derived 
neurotrophic factor (BDNF), an established marker of activity-dependent neuronal plasticity 
(Fontinha et al. 2008). Cortical Bdnf in rats is higher after wakefulness than after sleep and increased 
after sleep deprivation (Conti et al., 2007). Chronic caffeine treatment appears to preserve the levels 
of BDNF in the sleep-deprived brain (Alhaider et al. 2011). Finally, A2A receptors co-localize with 
metabotropic glutamate receptors of subtype 5 (mGluR5), which induce BDNF expression and 
stimulate gliotransmission. The mGluR5 are primarily expressed on post-synaptic neurons and glia 
cells and contribute importantly to long-term depression (Izumi et al. 2012), but also to long-term 
potentiation. It was recently found that sleep loss increases mGluR5 availability in the human brain, 
and this increase was closely correlated with increased sleepiness after a night without sleep (Hefti 
et al. 2013). 
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Whereas many studies investigated the effects of caffeine on the sleep-deprived brain, the possible 
roles for adenosine, adenosine receptor subtypes, and effects of caffeine in genetically distinct 
animals and humans on sleep-wake-related neuronal plasticity have only started to be explored. It is 
suggested that the further development of this avenue of research will permit a better 
understanding of sleep as a fundamental brain process. This knowledge may then lead to the 
rational development of more effective treatment and countermeasure strategies, not only of 
impaired vigilance and attentional processes but also of reduced higher-order cognitive functions, in 
conditions of sleep deprivation, shiftwork and jet-lag, for example. Such strategies are highly 
important for public health and personal safety.  
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Legends to the Figures 
Figure 1. Overview and simplified global classification of the main cognitive processes. See (Schmidt 
et al. 2007) for more detailed explanations. 
Figure 2. Schematic representation of adenosine formation, metabolism, and transport. Neurons, 
astrocytes and microglia cells can release adenosine and adenosine-tri-phosphate (ATP; grey arrow). 
All cell types express adenosine receptors, adenosine transporters (cylinder) and ecto-nucleotidases 
that convert ATP into adenosine. A1, A2A, A2B, A3 = adenosine receptors coupled to corresponding G-
proteins; ADP = adenosine-di-phosphate; AMP = adenosine-mono-phosphate; SAH = S-adenosyl-
homocysteine; 5’-N = 5’-nucleotidase; AK = adenosine kinase; ADA = adenosine deaminase; SAHH = 
S-adenosyl-homocysteine hydrolase. 
Figure 3. Distribution of adenosine A1 and A2A receptors in the human brain. (A) Color-coded 
distribution volumes of the selective A1 receptor antagonist, 
18C-CPFPX (mean values of 10 healthy 
young men). From left to right: axial, coronal, and sagittal planes (coordinates according to the 
Montreal Neurological Institute brain atlas: z = -4, y = -12, x = 0). Unpublished data. (B) Color-coded 
distribution volumes of the selective A2A receptor antagonist, 
11C-KW6002 (istradefylline), in a 
healthy male volunteer. From left to right: axial, coronal, and sagittal sections. Figure modified from 
(Brooks et al. 2008). 
Figure 4. Functional variants of genes contributing to adenosine metabolism (adenosine deaminase, 
ADA) and signal transmission (adenosine A2A receptor, ADORA2A) contribute to inter-individual 
differences in psychomotor vigilance during prolonged wakefulness. Starting 30 minutes after wake-
up from the baseline night, a 10-min psychomotor vigilance task (PVT) was administered at 3-hour 
intervals during 40 hours prolonged wakefulness. Ticks on the x-axis are rounded to the nearest 
hour. The time courses of median speed (1/reaction times) are illustrated; error bars indicate + or - 1 
SEM. Data were analyzed with 2-way ANOVA models with the factors ‘genotype’ (G/A, G/G) or 
‘haplotype’ (HT4, non-HT4) and ‘session’ (14 assessments during prolonged waking). (A) Blue circles: 
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G/A genotype (n = 11). Grey circles: G/G genotype (n = 11). The G/A genotype of ADA performs 
worse than the G/G genotype throughout prolonged waking (‘genotype’: F1,25 = 15.4, p < 0.001; 
‘session’: F13,239 = 38.6, p < 0.001; ‘genotype’ x ‘session’ interaction: F13,146 = 0.3, p > 0.9). Data were 
re-plotted from (Bachmann et al. 2012). (B) Red squares: Carriers of HT4 haplotype alleles (n = 6). 
Grey squares: Carriers of HT4 haplotype alleles (n = 17). See (Bodenmann et al. 2012) for details of 
genetic analyses. Individuals with haplotype HT4 performed faster than non-HT4 allele carriers 
throughout sleep deprivation (‘haplotype’: F1,21 = 9.3, p = 0.006; ‘session’: F13,273 = 16.3, p < 0.001; 
‘haplotype’ x ‘session’ interaction: F13,273 = 0.9, p > 0.5). Data were re-analyzed from (Bodenmann 
and Landolt 2010). 
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